We conducted a study of the prevalence of sleep-disordered breathing in subjects derived from a random sample of the population. A total of 2,202 subjects 35 to 69yr of age were approached. Four hundred forty-one answered a questionnaire concerning their sleep symptoms, general health, and habits such as alcohol consumption, and they were monitored for sleep-disordered breathing (SDB The apparent disease prevalence reported by these studies varies from as little as 0-3% to as much as 15% (table) . The Oxford prevalence studyl' and the study by
being the one which addresses prevalence. This study, together with several other similar studies, attempts to define the community frequency of abnormal breathing during sleep. However, there are still important questions about the apparently widely differing prevalences in these studies and the overall significance of these figures for the understanding of obstructive sleep apnoea and its health care ramifications. This commentary deals with these issues.
How common is disturbed breathing during sleep? The first and superficially simplest question concerns the prevalence of disturbed breathing during sleep in the normal population. There are now at least 12 large studies of adults from seven countries and four continents addressing this question (table The apparent disease prevalence reported by these studies varies from as little as 0-3% to as much as 15% (table) . The Oxford prevalence studyl' and the study by
Olson et al2 lie towards opposite ends ofthis spectrum. In practice, the results of these studies are more in agreement than it first appears -it is not true that sleep apnoea is about 50 times more common in Australia than it is in Oxford! To illustrate this point, the Oxford results will be reanalysed and compared with those reported by Olson et al in the introductory article. Some of the data corrections presented during this re-analysis are necessarily approximate and the calculated prevalences are therefore also probably inexact and should be interpreted in this light.
The definition of what constitutes significant sleep apnoea is critical in these studies. In any large population sample the severity of sleeping respiratory disturbance is unimodally distributed, there being no discrete subgroup who "have the disease". Hence, the selection of a single diagnostic cut-off point above which breathing is "abnormal" is misleading. Figure 1A shows the population distribution of nocturnal hypoxaemic dipping (which indicates transient hypoventilation or apnoea) in the 893 randomly selected normal men from the community studied in the Oxford prevalence study.'0 Clearly it makes a large difference to the apparent disease prevalence whether a threshold of >5 becomes very common,2122 probably due mainly to sleeping periodic breathing associated with cerebrovascular disease, heart failure, and a reduced sleep depth. The high prevalence of sleep disordered breathing reported by Olson et al in subjects aged 65-69, of whom 40% showed >15 respiratory events per hour, may partly be explained by this. However, most of the excess of periodic breathing in the elderly is seen in people aged over 70 and Olson et a12 did not study patients as old as this. In younger patients non-obstructive causes of sleep apnoea represent <1% of the abnormal cases seen in a sleep laboratory, 15 and clinically well subjects with significant central sleep apnoea are virtually unknown. Indeed, so uncommon is truly central sleep apnoea in well subjects from younger age groups that the majority of subjects with "central sleep apnoea" by polysomnographic criteria actually have primarily obstructive apnoea with reflex suppression of respiratory effort secondary to their pharyngeal collapse.23 It is therefore most unlikely that many cases of undiagnosed truly central sleep apnoea exist in the community to distort the results of prevalence studies, but which escape detection in sleep laboratories.
Another approach to this question is to assess whether the numerous subjects with disordered breathing during sleep also have the other symptoms which would be expected if their breathing abnormality is primarily obstructive. Olson The estimate that 1-5% of the male population has the "sleep apnoea syndrome" may be an overestimate oftrue community prevalence since some ofthese hypersomnolent subjects in the community with sleep apnoea will have a proportion of their sleepiness explained by non-respiratory factors. Figure 2 shows the interrelationships between objective breathing abnormalities during sleep and subjective daytime sleepiness calculated from the two largest sleep apnoea prevalence studies based on breathing criteria assessments.2 12 From these calculations the frequency of subjects reporting themselves to be sleepy in the subgroup with an objective nocturnal breathing abnormality is not statistically significantly increased compared with the parent population. This emphasises that, despite the obvious severe and treatment responsive sleepiness frequently seen in patients attending a hospital clinic,2425 in the general population much of the community burden of hypersomnolence is attributable to non-respiratory factors.
The other main reason advanced for the treatment of obstructive sleep apnoea is the reduction ofan associated cardiovascular disease risk. There is no doubt that patients with obstructive sleep apnoea show an excess of hypertension, coronary heart disease, stroke, and sudden death.25 It remains unclear, however, whether this is directly due to their sleep apnoea or the confounding cardiovascular risk factors which co-correlate with sleep apnoea, particularly obesity.25 This problem -and many of the methodological difficulties which make its resolution difficult -are well illustrated in the study by Olson et al.3 They found clear associations between sleep apnoea and hypertension, coronary heart disease, and occlusive vascular disease, but these could be explained by the confounding effects of age, sex, obesity, smoking, and alcohol intake. A full discussion of the issues relating to the risk of vascular disease is inappropriate here and is fully explored elsewhere."253536 Although sleep apnoea is associated with dramatic nocturnal haemodynamic instability and an overall nocturnal rise in blood pressure,37 it remains unclear how these events relate to daytime vascular consequences.
Conclusions
The literature on the prevalence of obstructive sleep apnoea is superficially complex and conflicting. However, the actual situation is probably clearer than the literature suggests. When methodological and disease definition factors are considered, about 1-5% of adult men, and rather fewer women, have the "sleep apnoea syndrome" (objective breathing abnormalities during sleep associated with daytime sleepiness). Due to population differences in obesity, this syndrome is more common in the USA and Australia than it is in the UK. Like non-insulin dependent diabetes and asthma, obstructive sleep apnoea is an extremely common disease in which stratified therapy is required. This needs to be adjusted to the patient's symptoms and disease complications and not just based on simple study criteria. The evolution ofservices and treatment techniques to manage this disorder appropriately must continue since the epidemiological studies have now shown that the prevalence of this problem is too great to ignore.
